300+ investors in your industry, stage, and region Get
Any industry
EdTech
Venture Capital
Video Games
Hospitality
Restaurants
Crowdfunding
Financial Services
Construction
Mobile
Photography
Cryptocurrency
Digital Media
Big Data
Email
Artificial Intelligence
Clean Energy
Non Profit
Energy
SaaS
Google
CleanTech
Social Impact
Consumer
Health Care
Enterprise Software
Local
Travel
Platforms
InsurTech
Oil and Gas
Film
Retail
Payments
Marketplace
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Medical Device
Wellness
Education
Sports
Legal
Automotive
eSports
Biotechnology
Renewable Energy
Software
Facebook
Blockchain
Theatre
Medical
Web3
Recruiting
Beauty
Fashion
Infrastructure
Social
Celebrity
Cannabis
LGBT
Climate
Food and Beverage
Life Science
Publishing
Wine and Spirits
Mobile Apps
Real Estate
Sporting Goods
Music
Art
Finance
Manufacturing
Social Media
FinTech
Franchise
Internet
Mobile Advertising
Android
Impact
Proptech
Hardware
Transportation
Biotech
Sustainability
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Singapore
Burkina Faso
Africa
LATAM
Egypt
United Kingdom
Oceania
Argentina
Tunisia
Taiwan
Zimbabwe
Faroe Islands
South Korea
Hong Kong
Benin
Nigeria
Togo
Croatia
Gibraltar
Guinea
Kyrgyzstan
Sudan
Norway
Haiti
Malawi
Iran
Isle of Man
Madagascar
Lesotho
Russian Federation
Nepal
Turkey
Liberia
Pakistan
Mexico
Tajikistan
Sweden
Oman
Zambia
Romania
Puerto Rico
Poland
Guernsey
Cameroon
Colombia
Armenia
China
Côte d'Ivoire
Costa Rica
Czech Republic
Marshall Islands
Kuwait
Malta
Luxembourg
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
Morocco
New Zealand
Jamaica
Sri Lanka
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Botswana
Uruguay
Moldova
Seychelles
Paraguay
South Africa
France
Denmark
Georgia
Ghana
Iraq
Philippines
Portugal
Sierra Leone
El Salvador
Senegal
Germany
India
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Bahamas
Bahrain
Jersey
Estonia
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Grenada
Israel
Honduras
Lithuania
Cambodia
Iceland
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
China Life Investment Holding, VC Fund

China Life Investment Holding

VC Fund

Beijing, China

China Life Investment Holding is an investment platform for China Life’s magnificent vision in healthcare sector, focusing on investment opportunities of premiu-quality companies along the industry chain of healthcare. It is committed to give full play to the driving role of commercial insurance, and deeply promote the integration and developmentof healthcare and insurance service, so as to meet diversified medical service and insurance protection demands of customers. Leveraging China Life’s massive resources, the Company can enrich portfolio companies’ customer base and provide insurance solutions integrally hence accelerating developments of portfolio companies. In addition, through cooperation and collaboration with portfolio companies, China Life can better serve its customers with premium-quality, convenient and integrated insurance, healthcare and medical solutions, and make a contribution to healthcare industry’s development and evolvement in China.

Total investments:
9
Last investment:
Lead investor:
44%

Last updated:

Industries China Life Investment Holding invests in

ManufacturingBiopharmaBiotechnologySemiconductorMedical Device

Stages China Life Investment Holding invests in

Series CSeries DSeries BFunding RoundPrivate Equity

Countries China Life Investment Holding invests in

China

Investment Focus

Industry

  • Manufacturing 5 (56%)
  • Biopharma 3 (33%)
  • Biotechnology 2 (22%)
  • Semiconductor 2 (22%)
  • Medical Device 2 (22%)
See all 21 industries →

Stage

  • Series C 4 (44%)
  • Series D 2 (22%)
  • Series B 1 (11%)
  • Funding Round 1 (11%)
  • Private Equity 1 (11%)

Investments

CompanyDescriptionRoundLinks
Volant Aerotech Volant Aerotech
Volant Aerotech is a company specializing in the R&D, manufacturing, and service of passenger eVTOL, an electric vertical take-off and landing aircraft. $147.4M / Series C / May 27, 2026
Shenzhen Energy Environmental Protection Co. Shenzhen Energy Environmental Protection Co.
Shenzhen Energy Environmental Protection Co. is a waste disposal company providing research, engineering design, and operation management. $691.7M / Mar 11, 2025
Guizhou Core Long March Technology (Marching Power) Guizhou Core Long March Technology (Marching Power)
Core Long March Technology is a high-tech design company specializing in the development of new power semiconductor devices. Its core business includes: coolmos, SiC and other chip products and technology development. The technical team is based on the technical experts of the Chinese Academy of Sciences and the introduction of outstanding overseastechnical elites. The core members of the team have more than 6 years of product development experience, and realize the whole chain from chip design, manufacturing process, packaging and testing, reliability and application. The company has a professional marketing and operation management team. It is very familiar with the technology, industry and market in this direction and has good operational capabilities. The technical and management teams have gone through the process from technology development to sample to product to mass production to complete marketization. . Series D / Jan 09, 2023
Eswin Eswin
Eswin provides IC application solutions in mobile devices, smart homes, smart transportation, industrial IoT, produces 12-inch monocrystalline silicon polished wafers and epitaxial wafers, and delivers rear-end IC packaging and testing services, according to its website. It operates R&D centers in China, the U.K., and South Korea, and hasproduction facilities in Xi'an, Chengdu, Hefei and Suzhou. $567M / Series C / Dec 09, 2022
Eswin Materials
Eswin Materials manufactures electronic-grade silicon single crystal polished wafers and epitaxial wafers for electronic and EV industries. $574.9M / Series C / Dec 09, 2022
Taibang Biological Group Taibang Biological Group
China Biologic Products Holdings, Inc. (NASDAQ: CBPO), is a leading fully integrated plasma-based biopharmaceutical company in China. Their core capabilities include plasma collection, research and development, manufacturing, and commercialization of human plasma-based biopharmaceutical products. Their company was founded in 2002 and was listed onNASDAQ in 2009.Their products are used as critical therapies during medical emergencies and for the prevention and treatment of life-threatening diseases and immune-deficiency related diseases. Backed by robust research and development capabilities, they aim to capture substantially all of the value along the plasma products value chain, and to develop their technology to enhance life quality and create value for more patients. They have expanded their product portfolio to eight categories of plasma-based products, including human albumin, immunoglobulin for intravenous injection and coagulation factor products, as well as other biopharmaceutical products, and they continue to make progress on new pipeline products. $300M / Private Equity / Aug 02, 2022
METiS Pharmaceuticals METiS Pharmaceuticals
METiS Pharmaceuticals is the world's first AI-driven drug formulation company. $150M / Series B / Apr 06, 2022
SiBionics SiBionics
SiBionics is a medtech specialized in R&D & commercialization of implantable medical devices and medical imaging artificial intelligence. $126M / Series C / Jan 21, 2022
Innovent Biologics Innovent Biologics
Innovent Biologics, Inc. is a privately held biopharmaceutical company that is dedicated to the development and manufacturing of monoclonal antibodies to be marketed in China and elsewhere around the world. Innovent is funded by the venture arm of Fidelity, which is a major investment firm in the US, Lilly Ventures, and Suzhou bioBay. Theregistered capital is 30Million US Dollars. The founders and senior management team of Innovent have over 70 years of combined work experience in the discovery, development and manufacture of biologics in the US, Europe and worldwide and were involved in the launch of such products as Bexxar, Conbercept, Natrecor, Oncorine, Recombivax HB, and others. $260M / Series D / Nov 29, 2016

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
EdTech
Venture Capital
Video Games
Hospitality
Restaurants
Crowdfunding
Financial Services
Construction
Mobile
Photography
Cryptocurrency
Digital Media
Big Data
Email
Artificial Intelligence
Clean Energy
Non Profit
Energy
SaaS
Google
CleanTech
Social Impact
Consumer
Health Care
Enterprise Software
Local
Travel
Platforms
InsurTech
Oil and Gas
Film
Retail
Payments
Marketplace
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Medical Device
Wellness
Education
Sports
Legal
Automotive
eSports
Biotechnology
Renewable Energy
Software
Facebook
Blockchain
Theatre
Medical
Web3
Recruiting
Beauty
Fashion
Infrastructure
Social
Celebrity
Cannabis
LGBT
Climate
Food and Beverage
Life Science
Publishing
Wine and Spirits
Mobile Apps
Real Estate
Sporting Goods
Music
Art
Finance
Manufacturing
Social Media
FinTech
Franchise
Internet
Mobile Advertising
Android
Impact
Proptech
Hardware
Transportation
Biotech
Sustainability
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Singapore
Burkina Faso
Africa
LATAM
Egypt
United Kingdom
Oceania
Argentina
Tunisia
Taiwan
Zimbabwe
Faroe Islands
South Korea
Hong Kong
Benin
Nigeria
Togo
Croatia
Gibraltar
Guinea
Kyrgyzstan
Sudan
Norway
Haiti
Malawi
Iran
Isle of Man
Madagascar
Lesotho
Russian Federation
Nepal
Turkey
Liberia
Pakistan
Mexico
Tajikistan
Sweden
Oman
Zambia
Romania
Puerto Rico
Poland
Guernsey
Cameroon
Colombia
Armenia
China
Côte d'Ivoire
Costa Rica
Czech Republic
Marshall Islands
Kuwait
Malta
Luxembourg
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
Morocco
New Zealand
Jamaica
Sri Lanka
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Botswana
Uruguay
Moldova
Seychelles
Paraguay
South Africa
France
Denmark
Georgia
Ghana
Iraq
Philippines
Portugal
Sierra Leone
El Salvador
Senegal
Germany
India
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Bahamas
Bahrain
Jersey
Estonia
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Grenada
Israel
Honduras
Lithuania
Cambodia
Iceland
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does China Life Investment Holding invest in?

China Life Investment Holding invests primarily in Manufacturing, Biopharma and Biotechnology startups, most often at Series C and Series D stage. Most of the 9 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

When did China Life Investment Holding last invest?

The most recent investment recorded for China Life Investment Holding closed in May 2026. Shizune tracks 9 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
China Life Investment Holding China Life Investment Holding Find emails